Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trial (Q30807010)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trial |
scientific article |
Statements
1 reference
Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trial (English)
1 reference
Maxime Dougados
1 reference
Bernard Combe
1 reference
Xavier Mariette
1 reference
Jérémie Sellam
1 reference
Sandrine Marion-Thore
1 reference
Florent Dumont
1 reference
Sébastien Jacques
1 reference
Henri-Jean Garchon
1 reference
Stéphanie Rouanet
1 reference
Yassine Taoufik
1 reference
Houria Hendel-Chavez
1 reference
Jean Sibilia
1 reference
Jacques Tebib
1 reference
Gilles Chiocchia
1 reference
1 August 2014
1 reference
1 reference
66
1 reference
2015-2025
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference